Skip to main content
Fig. 5 | Journal of Ovarian Research

Fig. 5

From: A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin

Fig. 5

Impact of peri- and post-surgical cisplatin treatment on tumor burden. Bioluminescence data are shown to compare the impact of day of cisplatin administration within groups that had received ICS (A-C) or no surgery (D-F). A and D Comparison of Day 0 vs. Day 7 cisplatin administration. B and E Comparison of Day 0 vs. Day 28 cisplatin administration. C and F Comparison of Day 7 vs. Day 28 cisplatin administration. Points indicate the mean ± SEM. Data collected at each imaging time point were analyzed by ANOVA followed by Fisher LSD test, *p<0.05. Abbreviations are defined in the legend to Fig. 3

Back to article page